ml 7 has been researched along with Colitis in 2 studies
ML-7 : An N-sulfonyldiazepane resullting from the formal condensation of 5-iodo-1-naphthylsulfonic acid with one of the nitrogens of 1,4-diazepane. It is a selective inhibitor of myosin light chain kinase (EC 2.7.11.18).
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conlin, VS | 1 |
Wu, X | 1 |
Nguyen, C | 1 |
Dai, C | 1 |
Vallance, BA | 1 |
Buchan, AM | 1 |
Boyer, L | 1 |
Jacobson, K | 1 |
Liu, X | 1 |
Xu, J | 1 |
Mei, Q | 1 |
Han, L | 1 |
Huang, J | 1 |
2 other studies available for ml 7 and Colitis
Article | Year |
---|---|
Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
Topics: Animals; Anti-Inflammatory Agents; Azepines; Bacterial Adhesion; Bacterial Translocation; Caco-2 Cel | 2009 |
Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice.
Topics: Animals; Azepines; Colitis; Cytokines; Dextran Sulfate; Enzyme Inhibitors; Gene Expression Regulatio | 2013 |